qPCR derived Ct’s for ctDNA positive cases used in ctDNA% calculation.
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
(XLSX)
应用场景：
创建时间：
2021-06-10
相关数据集
Table_6_Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.xlsx
IntroductionAnalyzing liquid biopsies for tumor-specific aberrations can facilitate detection of measurable residual disease (MRD) during treatment and at follow-up. In this study, we assessed the cli
NIAID Data Ecosystem30
Supplementary Material for: Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors
Introduction Neuroendocrine tumors (NETs) are a rare and heterogeneous group of neoplasms with both clinical and genetic diversity. The clinical applicability of molecular profiling using liquid biops
DataCite Commons2025-09-08 更新00
DataSheet_1_Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases.docx
BackgroundBrain metastases (BM), including brain parenchyma metastases (BPM) and leptomeningeal metastases (LM), are devastating metastatic complications in advanced cancer patients. Next-generation s
NIAID Data Ecosystem00
Machine Learning Models for cfMeDIP data from Shen et al.
Contains raw markdowns and knit markdown with plots for machine learning analyses in Shen et al, " Highly sensitive tumor detection and classification using methylome analysis of plasma cell-fr
Zenodo2020-09-20 更新00
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics
Early detection of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors (PNST) informs clinical decision-making, potentially averting deadly outcomes. Here, we describe a cell-free
NIAID Data Ecosystem00
